Kurokawa T - Search Results

1

A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34(+)-selection method in cyclin D1(+)-mantle cell lymphoma.

Uehira K, Kagami Y, Ogura M, Suzuki R, Miura K, Tachi H, Kurokawa T, Kinoshita T, Murate T, Nakamura S, Morishima Y. Uehira K, et al. Among authors: kurokawa t. Int J Hematol. 1998 Feb;67(2):187-90. doi: 10.1016/s0925-5710(97)00097-2. Int J Hematol. 1998. PMID: 9631586

2

Complementarity determining region-III is a useful molecular marker for the evaluation of minimal residual disease in mantle cell lymphoma.

Kurokawa T, Kinoshita T, Murate T, Nagasaka T, Kagami Y, Ogura M, Nakamura S, Seto M, Hotta T, Saito H. Kurokawa T, et al. Br J Haematol. 1997 Aug;98(2):408-12. doi: 10.1046/j.1365-2141.1997.2133030.x. Br J Haematol. 1997. PMID: 9266940 Free article.

3

Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.

Ogura M, Kagami Y, Suzuki R, Miura K, Uehira K, Kurokawa T, Ito T, Kinoshita T, Emi N, Morishima Y, Kodera Y, Ueda R. Ogura M, et al. Among authors: kurokawa t. Cancer Chemother Pharmacol. 1997;40 Suppl:S51-7. doi: 10.1007/s002800051062. Cancer Chemother Pharmacol. 1997. PMID: 9272135 Clinical Trial.

4

Molecular evaluation of bone marrow involvement in peripheral T-cell lymphoma with a PCR-mediated RNase protection assay.

Hanamura A, Kinoshita T, Kurokawa T, Nagai H, Murate T, Nagasaka T, Mori H, Saito H. Hanamura A, et al. Among authors: kurokawa t. Int J Hematol. 1999 Dec;70(4):283-9. Int J Hematol. 1999. PMID: 10643155

5

Detection of minimal residual disease B cell lymphoma by a PCR-mediated RNase protection assay.

Kurokawa T, Kinoshita T, Ito T, Saito H, Hotta T. Kurokawa T, et al. Leukemia. 1996 Jul;10(7):1222-31. Leukemia. 1996. PMID: 8684006 Clinical Trial.

6

Dyggve-Melchior-Clausen syndrome without mental retardation (Smith-McCort dysplasia): morphological findings in the growth plate of the iliac crest.

Nakamura K, Kurokawa T, Nagano A, Nakamura S, Taniguchi K, Hamazaki M. Nakamura K, et al. Among authors: kurokawa t. Am J Med Genet. 1997 Oct 3;72(1):11-7. Am J Med Genet. 1997. PMID: 9295067

7

Neuronal localization of fibroblast growth factor-9 immunoreactivity in human and rat brain.

Todo T, Kondo T, Nakamura S, Kirino T, Kurokawa T, Ikeda K. Todo T, et al. Among authors: kurokawa t. Brain Res. 1998 Feb 9;783(2):179-87. doi: 10.1016/s0006-8993(97)01340-1. Brain Res. 1998. PMID: 9507114

8

Expression and growth stimulatory effect of fibroblast growth factor 9 in human brain tumors.

Todo T, Kondo T, Kirino T, Asai A, Adams EF, Nakamura S, Ikeda K, Kurokawa T. Todo T, et al. Among authors: kurokawa t. Neurosurgery. 1998 Aug;43(2):337-46. doi: 10.1097/00006123-199808000-00098. Neurosurgery. 1998. PMID: 9696088

9

Polylactide screws in acetabular osteotomy. 28 dysplastic hips followed for 1 year.

Nakamura S, Ninomiya S, Takatori Y, Morimoto S, Kusaba I, Kurokawa T. Nakamura S, et al. Among authors: kurokawa t. Acta Orthop Scand. 1993 Jun;64(3):301-2. doi: 10.3109/17453679308993630. Acta Orthop Scand. 1993. PMID: 8322585

10

FGF-9 is an autocrine/paracrine neurotrophic substance for spinal motoneurons.

Kanda T, Iwasaki T, Nakamura S, Ueki A, Kurokawa T, Ikeda K, Mizusawa H. Kanda T, et al. Among authors: kurokawa t. Int J Dev Neurosci. 1999 Jun;17(3):191-200. doi: 10.1016/s0736-5748(99)00026-x. Int J Dev Neurosci. 1999. PMID: 10452363

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,251 results

Search Page

Filters